Male Wistar rats of various age groups were injected daily over a period of 3 weeks with iproniazid (10,ug/g body wt.) and L-dihydroxyphenylalanine (L-dopa; 0.1 mg/g body wt.). On the final day 1 h before the termination of the experiment the animals were injected with L414CIvaline (0.1,Ci/g body wt.). The specific radioactivity of the valine in the proteins of the subcellular fractions of the tissues examined, relative to the time-integrated mean specific radioactivity of this amino acid in the acid-soluble pools of these tissues, was used to assess protein synthesis. The L-dopa/monoamine oxidaseinhibitor treatment was associated with 30-40% inhibition of protein synthesis. Supplementation of the dietary methionine intake by injection of this amino acid markedly diminished the inhibitory action of the L-dopa/monoamine oxidase-inhibitor treatment on protein synthesis in all fractions examined.
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The therapeutic efficacy of L-dihydroxyphenylalanine (L-dopa) in the treatment of Parkinson's disease has been correlated with the efficiency of its uptake by the brain and its physiological role as precursor of the neutrotransmitter dopamine. However, a cautionary note regarding its use has been introduced into the literature after the observations of Weiss et al. (1972, 1974, 1975 ) that a marked increase in brain dopamine concentration could lead to brain polyribosome disaggregation with a consequent detrimental effect on brain protein biosynthesis (Taufek, 1977; Bone, 1975) . In contrast the electron-microscopic studies by Hartman & Becker (1973) and Taufek (1977) yielded no ultrastructural evidence indicating disaggregation of brain polyribosomes in vivo after the administration of L-dopa. Furthermore, King & Beesley (1978) , by using procedures that included the gross injection technique of Dunlop et al. (1975) , concluded that L-dopa causes little or no inhibition of protein synthesis.
In both man and experimental animals given L-dopa much of this amino acid as well as its metabolic products undergo O-methylation before excretion (Calne et al., 1969; Wurtman et al., 1970) . The therapeutically effective dosage of L-dopa is often quite high and correspondingly large amounts of S-adenosylmethionine will be irreversibly utilized for the transmethylation involved. This may cause Vol. 192 the concentration of S-adenosylmethionine in the brain and other organs to be substantially decreased. Repetitive doses of L-dopa over a period of several weeks were found to cause a marked depletion of S-adenosylmethionine and methionine concentrations in both the brain and other organs, e.g. the liver and kidneys (Taufek & Bone, 1979) . The depletion of this amino acid, essential for the initiation of protein biosynthesis and an indispensable component of the majority of the proteins formed, may at least in part be responsible for the impairment of the process of protein synthesis by L-dopa/dopamine.
Materials and methods
The animals used throughout these investigations were male albino rats of the Wistar strain. Observations were made on the following age groups (age given at time of first injection): 20-day-old, 40-day-old and 80-90-day-old. Each group was made up of 20 animals, 10 experimental and 10 controls.
All animals were fed ad lib. with the C.R.M. Labsure rat diet with free access to water throughout the investigations.
The experimental animals were injected daily via the caudal vein over a period of 3 weeks with the monoamine oxidase inhibitor iproniazid phosphate 0306-3283/80/1 10703-05$01.50/1 © 1980 The Biochemical Society (10,ug/g body wt.) in suspension of concentration lmg/ml in physiological saline. This was followed after a period of 5 min by an intraperitoneal injection of L-dopa (0.1 mg/g body Wt.) in a warm (370 C) saline suspension containing the non-ionic detergent Tween 80 (0.2%, v/v). This combination of L-dopa and monoamine oxidase inhibitor was sufficient to maintain an increased concentration of L-dopa and dopamine in the tissues over the greater part of the 24 h period after the injection (see Figs. 1 and 2 ).
The controls were treated in the same manner as the experimental animals with the exception that L-dopa was replaced by an equivalent volume of warm physiological saline containing 0.2% (v/v) Tween 80. Experiments were also carried out in which the dietary methionine was supplemented by the daily injection of this amino acid (0.1 mg/day per g body wt.) (dissolved at a concentration of 50mg/ml) in physiological saline. This was also administered via the intraperitoneal route, contralateral to the site of injection of the L-dopa or placebo.
Control experiments for these analyses were of two types: (a) animals that received supplementary methionine and monoamine oxidase inhibitor in saline; (b) animals that received monoamine oxidase inhibitor in saline only.
On day 21 of treatment animals to be used for protein-synthesis studies were injected immediately after and contralateral to the L-dopa or placebo injection with L-l '4Clvaline of specific radioactivity lOmCi/mol (0.1,pCi/g body wt.). The utilization of valine of this low specific radioactivity and high dosage was based on the work of Taufek (1977) and Dunlop et al. (1975) . The method overcomes the problem of the rapid catabolism of radiolabelled amino acids of high specific radioactivity at low dosage. The animals were then maintained in a warm environment (25 ± 1 OC) for exactly 1 h. They were then lightly anaesthetized with N20/02 (1:1) mixed with fluothane. The chest was opened and the liver was perfused briefly with physiological saline through the portal vein. The liver, kidneys and brain were then rapidly excised, rinsed with cold (50C) saline and frozen in liquid N2. All tissues were weighed in the frozen state, taking appropriate precautions to prevent moisture condensation. The specimens were maintained at -200C until analysed. The extraction and fluorimetric assay of the L-dopa and dopamine content of the tissues was carried out by the method of Anton & Sayre (1962) .
The extraction, partial purification and fluorimetric assay of monoamine oxidase activity in the tissues was carried out by the method of Krajl (1965) . This assay is based on the formation of a hydroxyquinone from kynuramine under the action of the enzyme. The degree of inhibition of monoamine oxidase activity by iproniazid under the conditions used in the protein-synthesis studies was thereby found to be )98% in all tissues examined. The specific radioactivity of the L-P and the amino acid content of, the acidof cerebral, hepatic and renal t determined as previously described for by Sabri et al. ( 1974) .
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The percentage inhibition of protein biosynthesis (as defined above) in the various subcellular fractions of the organs of the animals given L-dopa + iproniazid ranged from 27 to 36%. The degree of inhibition was markedly diminished by supplementation of the methionine intake of the treated animals. The improvement was somewhat greater in the more adult animals (Tables 1-3) . Although not strictly comparable, owing to differences in experimental procedure, these results contrast markedly with those of King & Beesley (1978) . These workers concluded from a rather limited number of experiments that L-dopa treatment has little effect on brain protein synthesis. The discrepancy may result from the far longer period of maintenance of the increased L-dopa/dopamine tissue concentrations in our own experiments. However, in most of their experiments the animals were decapitated and brain protein synthesis was during the To define the specific radioactivity of the precursor amino-acid pool as that found at the time of 23 Table 1 . Effect ofL-dopa in the presence ofa monoamine oxidase inhibitor, with and without methionine supplementation, on protein synthesis in the tissues of20-day-old rats The protein specific radioactivities are given as means + S.E.M. (10 animals per group). The time-integrated mean specific radioactivities of the L-[P"Civaline in the brain, liver and kidney amino-acid pools were assessed graphically by the method of Sabri et al. (1974) . An example of this assay is given in Fig. 3 . The control refers to animals given iproniazid alone. 'Experimental' refers to animals given iproniazid+L-dopa. 'Experimental with methionine' refers to animals given iproniazid + L-dopa + methionine In each example of the protein-synthesis study there is a significant decrease (two-tail t test P <0.002) in the incorporation of the labelled amino acid into the proteins of each of the subcellular fractions of the experimental (iproniazid + L-dopa-treated) animals compared with the controls. This effect is partially alleviated by methionine supplementation. (Starr & Sells, 1969) .
Subcellular
There is also an apparent conflict regarding our own conclusion that methionine + S-adenosylmethionine depletion is in part responsible for the inhibition of protein synthesis and the observations by Weiss et al. (1972) that depletion of S-adenosylmethionine by use of D-dopa does not lead to polyribosomal disaggregation. The conflict, however, is more "apparent" than real, owing to the differences in experimental conditions used. Whereas in our own experiments the concentrations of both S-adenosylmethionine and of methionine remained decreased over a period of 3 weeks in those of Weiss et al. (1972) no depletion of methionine occurred in brain tissue and depletion of S-adenosylmethionine was maintained only for a 1 h period. These processes may be responsible for the methionine-reversible component of the inhibitory effect of dopamine on protein biosynthesis. They may also explain the apparently different effects observed on polyribosome profiles when examined by different techniques, because of their influence on the stability of the polyribosome structure.
